Thomas A. Raffin
CIK 1512119 · last filed 2025-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.32M
Companies
4
Total Filings
31
Lifetime Open-Market Net
-$23.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LUMOS PHARMA, INC. (LUMO) Delisted | Director | 0 | $4.34 | $0 | $9.7K | 7 | 2024-12-13 |
| Akoya Biosciences, Inc. (AKYA) Delisted | Director | 2,166,896 | $1.29 | $2.80M | $10.10M | 6 | 2024-06-05 |
| LUMOS PHARMA, INC. (NLNK) Delisted | Director | 64,621 | — | — | -$1.13M | 14 | 2019-08-02 |
| LDRH | 10%+ Owner | 338,057 | $24.62 | $8.32M | -$32.58M | 3 | 2014-10-21 |
Recent Filings · Page 3 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-17 | LUMOS PHARMA, INC. (NLNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-04 | LUMOS PHARMA, INC. (NLNK) Delisted | Grant (A) | +1,962 | $0 | EDGAR |
| 2015-04-09 | LUMOS PHARMA, INC. (NLNK) Delisted | Mixed | — | -$1.03M | EDGAR |
| 2014-10-21 | LDRH | Sell (S) | −320,000 | -$10.61M | EDGAR |
| 2014-09-26 | LDRH | Sell (S) | −800,000 | -$24.97M | EDGAR |
| 2014-01-06 | LUMOS PHARMA, INC. (NLNK) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2013-10-17 | LDRH | Mixed | +12,412,056 | $3.00M | EDGAR |
| 2013-05-10 | LUMOS PHARMA, INC. (NLNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-11-06 | LUMOS PHARMA, INC. (NLNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-18 | LUMOS PHARMA, INC. (NLNK) Delisted | Conv (C) | +9,096 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.